Thani Jambulingam - Jan 1, 2023 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 07:30 PM
Previous filing
Jan 5, 2022
Next filing
Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +40K $0.00 40K Jan 1, 2023 Common Stock 40K $0.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.